(c) 2024 PillSync.com

Zolpidem tartrate 5 mg

1 INDICATIONS AND USAGE Zolpidem tartrate tablets are indicated for the short-term treatment of insomnia characterized by difficulties with sleep initiation. Zolpidem tartrate tablets have been shown to decrease sleep latency for up to 35 days in controlled clinical studies [see Clinical Studies ( 14 )]. The clinical trials performed in support of efficacy were 4 to 5 weeks in duration with the final formal assessments of sleep latency performed at the end of treatment. Zolpidem tartrate tablets are, a gamma-aminobutyric acid (GABA) A receptor positive modulator, is indicated for the short-term treatment of insomnia characterized by difficulties with sleep initiation. ( 1 )

American Health Packaging


1 year ago ROUND WHITE ZLP 5 Zolpidem tartrate 5 mg

ROUND WHITE ZLP 5

1 year ago ROUND WHITE ZLP 5 Zolpidem tartrate 5 mg

ZLP 5 ROUND WHITE

16 HOW SUPPLIED/STORAGE AND HANDLING

ZOLPIDEM TARTRATE tablets, USP are available as follows: 5 mg, are white, round-shaped, biconvex, film coated tablets, with ZLP debossed on one side and 5 on the other side. Unit dose packages of 100 (10 x 10) NDC 68084-189-01 Store at controlled room temperature 20° to 25°C (68° to 77°F). FOR YOUR PROTECTION: Do not use if blister is torn or broken.


More pills like ROUND ZLP 5

Related Pills

Zolpidem tartrate 5 MG Oral Tablet

American Health Packaging

Zolpidem tartrate 10 MG Oral Tablet

American Health Packaging

Zolpidem tartrate 5 MG Oral Tablet

American Health Packaging












DISCLAIMER:

"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."

"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."

"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."

PillSync may earn a commission via links on our site